BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20638606)

  • 1. Macrolide-resistant Streptococcus pyogenes from Chinese pediatric patients in association with Tn916 transposons family over a 16-year period.
    Feng L; Lin H; Ma Y; Yang Y; Zheng Y; Fu Z; Yu S; Yao K; Shen X
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):369-75. PubMed ID: 20638606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
    Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan.
    Huang CY; Lai JF; Huang IW; Chen PC; Wang HY; Shiau YR; Cheng YW; Hsieh LY; Chang SC; Lauderdale TL
    J Clin Microbiol; 2014 Feb; 52(2):508-16. PubMed ID: 24478481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China.
    Chang H; Shen X; Fu Z; Liu L; Shen Y; Liu X; Yu S; Yao K; Zhao C; Yang Y
    Scand J Infect Dis; 2010; 42(2):84-9. PubMed ID: 19883153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).
    Rubio-López V; Valdezate S; Alvarez D; Villalón P; Medina MJ; Salcedo C; Sáez-Nieto JA
    BMC Microbiol; 2012 Sep; 12():215. PubMed ID: 22998619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China.
    Li H; Zhou L; Zhao Y; Ma L; Liu X; Hu J
    BMC Infect Dis; 2020 Jul; 20(1):507. PubMed ID: 32660436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy.
    Olivieri R; Morandi M; Zanchi A; Tordini G; Pozzi G; De Luca A; Montagnani F
    J Med Microbiol; 2015 Oct; 64(10):1186-1195. PubMed ID: 26224594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.
    Muhtarova A; Mihova K; Markovska R; Mitov I; Kaneva R; Gergova R
    Acta Microbiol Immunol Hung; 2019 Dec; 67(1):14-17. PubMed ID: 31833385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.
    Pires R; Rolo D; Morais A; Brito-Avô A; Johansson C; Henriques-Normark B; Gonçalo-Marques J; Santos-Sanches I
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):849-57. PubMed ID: 22012657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan.
    Tanaka Y; Gotoh K; Teramachi M; Ishimoto K; Tsumura N; Shindou S; Yamashita Y
    J Infect Chemother; 2016 Nov; 22(11):727-732. PubMed ID: 27645122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
    Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
    J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
    Dundar D; Sayan M; Tamer GS
    Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
    Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
    Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in epidemiologic characteristics and antimicrobial resistance of
    Ubukata K; Wajima T; Morozumi M; Sakuma M; Tajima T; Matsubara K; Itahashi K; Iwata S
    J Med Microbiol; 2020 Mar; 69(3):443-450. PubMed ID: 32011228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.